ResMed (RMD) Tops Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $214.90 +2.51%
Revenue Growth %: +13.1%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +13.1%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.51, $0.15 better than the analyst estimate of $1.36. Revenue for the quarter came in at $904 million versus the consensus estimate of $860.89 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Solstice acquiring Element Solutions in $14.5B cash and stock deal
- Lynx Equity on Lam Research (LRCX): 'Closing in on full valuation'
- S&P Global restructures Market Intelligence into two units
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
